Patent Claims Allowed Covering Samaritan's Alzheimer's Memory Recovery Drug In Australia

Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has received notification that the claims in the patent application for "Neuroprotective Spirostenol Pharmaceutical Compositions" covering Caprospinol (SP-233) have been allowed by the Australian Patent Office. ...

Write comment to this article:

Subject:

Name:

email or site:

Code: